CLINICAL_TRIALS
trial_result
· 2023-06-27
Clinical Trial Update: Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer [Phase 2]
Summary
Phase II trial evaluating neck dissection-driven treatment stratification to improve quality of life for low-risk HPV-positive oropharyngeal squamous cell cance…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Michigan Rogel Cancer Center | Conditions: Oropharyngeal Squamous Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-06-27